Business Analytics | Equity & Project Valuation |  Management Consulting | Training

Let your sympathies and your compassion be always with the underdog in the fight - this is magnanimity

But bet on the other one - this is business.

- Mark Twain

 Offerings | Scope of Services

Business Consultancy

Analytics and Research: Introduce objective views with rigorous statistical analysis of underlying factors. Make informed and unbiased decisions through bespoke in-depth Marketing Research. You know your business better than anyone. But the consultant has spent a lifetime studying many others besides your own.

Valuation: Focus on Discounted Cash Flow tempered by robust modeling of volatility in underlying components to deliver superior ranging, econometric-weighted results, and scenario views. This illustrates valuations under an array of stressors.

Training

Excel Workbooks and Database: Enhance your firm's long-term value and quality of services. Cultivate your staffers to instill confidence to tackle day-to-day issues and conquer advanced approaches and solutions. 

Monte Carlo Approach: Introduce your staffers to advanced techniques to model volatility and scenarios. Oracle's Crystal Ball system integrates seamlessly into MS Excel to produce superior analytics and graphics to illustrate true ranges of outcomes following your parameters. No more: Best|Worst|Base. Learn to isolate the exact probabilities of Scenario Distribution.

Tutoring | School Prep

Academic Subjects: High School and University level coaching for Social Sciences and Business subjects. The consultant has instructed at high school and university level (including MBA) and possesses expertise in a range of subject matter:

2023-09-07_IMNN-MC-ValuationReport_Draft01B.pdf

Imunon, Inc. Equity Valuation and Recommendation

This is my current (05-September-2023) valuation project. Imunon is a long-lived (1982 inception) Biotech-Pharma R&D firm on the cusp of marketing new breakthroughs in vaccine production: PlaCCine; and oncology genetic/plasmid therapy: Theraplas. The analyst believes the firm is rapidly evolving into a full-fledged marketing/licensing Biotech entity with potential for positive Free CashFlow to Equity: FCFE by 2026.

2022-03-31_GILD-MC-ValuationReport_Draft03_2023-08-25_Sign.pdf

Gilead Sciences: GILD

31-March-2023 Equity Appraisal

2022-03-24_KHC_Valuation-Memo.pdf

Kraft Heinz: KHC

31-March-2023 Equity Appraisal

2023-03-24_LANC-MC-Equity_WKBK001.pdf

Lancaster Colony: LANC

31-March-2023 Equity Appraisal

2022-07-28_LMT-MC-ValuationReport_Draft03.pdf

Lockheed Martin: LMT

31-July-2022 Valuation Report

2023-07-06_BeharryLyndonMw_2023-CV001D.pdf

Key Personnel

Beharry, Lyndon Martin W.

故知勝者有五:知可以戰與不可以戰者勝,識眾寡之用者勝,上下同欲者勝,以虞待不虞者勝,將能而君不御者勝;此五者,知勝之道也
There are five essentials for victory: (1) He will win who knows when to fight and when not to fight. (2) He will win who knows how to handle both superior and inferior forces. (3) He will win whose army is animated by the same spirit throughout all its ranks. (4) He will win who, prepared himself, waits to take the enemy unprepared. (5) He will win who has military capacity and is not interfered with by the sovereign. These five are the way by which we know which side will win. ...Sun Tzu, the General

Personnel are still developing the below sections of this site:

Search organization content

 

Stay connected

HR policies

Quick links

Employee resource groups